Preoperative HALP index as a predictor of in-hospital mortality after type A aortic dissection surgery: a retrospective cohort study Authors: Zhen Chen, Zongxiang Lin, Qiuxia Liu, Pengfei Chen, Hao Chen Published: 2026 ABSTRACT AbstractObjectiveTo evaluate the predictive value of the preoperative haemoglobin–albumin–lymphocyte–platelet (HALP) index for in-hospital mortality in patients undergoing cardiopulmonary bypass (CPB)-assisted type A aortic dissection surgery.MethodsThis single-centre retrospective cohort study enrolled 750 adult patients who underwent type A aortic dissection surgery with CPB at a tertiary hospital from January 2021 to December 2025. The HALP index was calculated using preoperative laboratory data, with in-hospital mortality as the primary endpoint. Variables with p < 0.1 in univariate analysis were included in multivariate logistic regression to identify independent risk factors, and receiver operating characteristic (ROC) curves were used to assess the predictive performance of HALP and the combined model.ResultsThe in-hospital mortality rate was 12.8%. Patients in the mortality group had significantly lower HALP scores than survivors (49.27 ± 15.06 vs. 71.53 ± 25.98). Multivariate analysis identified age (OR = 1.06), chronic kidney disease (CKD) (OR = 2.71), reduced left ventricular ejection fraction (LVEF) (OR = 0.92) and low HALP (OR = 2.87) as independent predictors. ROC analysis showed that HALP (area under the curve (AUC) = 0.74) outperformed individual indicators (age, CKD, LVEF: AUC 0.60–0.65), and the combined model achieved the best predictive performance (AUC = 0.79).ConclusionsThe preoperative HALP index is an independent predictor of in-hospital mortality after type A aortic dissection surgery with CPB, with good discriminatory performance. As a simple and low-cost biomarker, it effectively supplements traditional risk scoring systems and supports preoperative risk stratification and clinical decision-making. Specifically, patients with low HALP values at admission may benefit from proactive blood product preparation, early nutritional support and intensified postoperative monitoring, thereby optimizing perioperative management and improving outcomes.Keywords: HALP index, type A aortic dissection, cardiopulmonary bypass, in-hospital mortality, prognostic prediction Introduction Type A aortic dissection is a catastrophic cardiovascular emergency, and surgical repair with cardiopulmonary bypass (CPB) is the only radical treatment modality [1]. Despite continuous advances in surgical techniques and perioperative management, postoperative mortality remains extremely high due to severe systemic inflammatory response, ischemia–reperfusion injury and hemodynamic instability induced by CPB and aortic dissection itself [2,3]. Reported in-hospital mortality rates after type A aortic dissection surgery range from 10% to 20% in clinical practice [4,5]. Accurate preoperative risk assessment is therefore critical for optimizing surgical decision-making and improving patient outcomes. Conventional risk assessment tools, such as EuroSCORE II and the STS score, are widely used in clinical practice; however, these systems primarily rely on demographic characteristics, comorbidities and surgical type, and fail to adequately capture patients’ nutritional and inflammatory-immune status [6,7]. Recent studies have highlighted that malnutrition and systemic inflammatory responses are important determinants of prognosis in type A aortic dissection patients undergoing surgical repair [8,9]. The interplay between nutritional status and immune function plays a pivotal role in postoperative recovery, with malnutrition and immune suppression significantly increasing the risk of complications and mortality [10]. In type A aortic dissection surgery with CPB procedures, patients are exposed to unique physiological stressors, including systemic inflammatory response syndrome (SIRS) triggered by extracorporeal circulation, marked hemodynamic fluctuations, ischemia–reperfusion injury, disturbances of coagulation and fibrinolysis, oxidative stress, and immune suppression [11,12]. These complex pathophysiological processes not only exacerbate postoperative organ injury but may also diminish the predictive accuracy of conventional risk scores [13]. Therefore, exploring novel risk assessment indices that integrate nutritional and immune information has become an important direction for improving the accuracy of risk prediction and enhancing clinical management in type A aortic dissection surgery. The haemoglobin–albumin–lymphocyte–platelet (HALP) index is a composite score derived from four routine laboratory parameters – haemoglobin, albumin, lymphocyte count and platelet count – and was initially proposed for prognostic evaluation in oncology patients [14]. This index comprehensively reflects nutritional status, inflammatory activity and hematopoietic function. Haemoglobin indicates oxygen delivery capacity and anaemia status; albumin serves as a marker of nutritional level and hepatic synthetic function; lymphocyte count reflects immune competence; and platelets participate in coagulation while being closely linked to inflammatory responses [15]. Studies have demonstrated that a low HALP index is independently associated with adverse outcomes in various cardiovascular conditions, including coronary slow flow [16], atrial fibrillation (AF) with acute coronary syndrome, and patients undergoing percutaneous coronary intervention [17]. Large-scale population-based evidence from the NHANES cohort further confirmed that a low HALP index is significantly associated with increased all-cause and cardiovascular mortality across the metabolic syndrome spectrum [18]. Compared with other commonly used composite indices, such as the prognostic nutritional index (PNI) and the platelet-to-lymphocyte ratio (PLR), HALP represents a novel inflammation–nutrition marker that is simple to measure, cost-effective and capable of dynamically reflecting immune imbalance and inflammatory status. It thus offers unique prognostic value in outcome prediction. Although the HALP index has demonstrated favourable prognostic value in oncology and certain cardiovascular diseases, studies specifically focusing on patients undergoing type A aortic dissection surgery with CPB remain scarce. To date, no dedicated investigation has examined the association between the HALP index and in-hospital mortality in this population. Against this background, the present study aimed to evaluate the predictive value of the preoperative HALP index for in-hospital mortality following type A aortic dissection surgery with CPB. The ultimate goal was to provide clinicians with a simple, low-cost and reproducible risk stratification tool to optimize perioperative management and improve patient outcomes. Methods Study design and participants This study adopted a single-centre retrospective cohort design, enrolling patients who underwent type A aortic dissection surgery with CPB in the Department of Cardiac Surgery at The Affiliated Hospital of Putian University between January 2021 and December 2025. Inclusion criteria: (1) age ≥18 years; (2) undergoing type A aortic dissection surgery with CPB; and (3) completion of relevant preoperative laboratory tests. Exclusion criteria: (1) presence of acute infection prior to surgery; (2) hematologic disorders or malignant tumours; (3) severe hepatic or renal dysfunction (Child–Pugh class C); (4) emergency surgery (non-elective repair for stable type A aortic dissection); and (5) incomplete clinical data. Surgical technique All operations were performed through a median sternotomy under general anaesthesia. CPB was established by cannulation of the right axillary artery (or femoral artery in selected cases) and the right atrium with a two-stage venous cannula. Myocardial protection was achieved with intermittent antegrade and retrograde cold blood cardioplegia delivered into the coronary ostia. Systemic cooling was initiated according to the planned operative strategy, and the distal anastomosis was performed under deep hypothermic circulatory arrest when arch involvement was present. The surgical strategy was individualized on the basis of the location of the primary entry tear and the extent of aortic involvement, as determined by preoperative contrast-enhanced computed tomography and intraoperative findings. After aortic transection, the intimal tear location and the anatomy of the aortic root and valve were carefully assessed. The proximal anastomosis was performed above the coronary ostia with a prosthetic Dacron graft. The distal anastomosis was extended to the hemiarch or total arch depending on the site of the primary tear and the involvement of arch vessels. In patients with the entry tear confined to the ascending aorta, ascending aorta replacement alone was performed. When the tear extended into the aortic arch or the arch vessels were compromised, hemiarch or total arch replacement was performed accordingly, with antegrade cerebral perfusion applied as needed. The aortic valve was managed according to intraoperative assessment. In patients with severe aortic regurgitation caused by leaflet prolapse or root dilatation, aortic valve replacement or valve-sparing root replacement was performed. Concomitant coronary artery bypass grafting was performed in patients with significant coronary artery disease identified on preoperative evaluation. All procedures were performed by the same senior surgical team. Despite individualized approaches, the core principles of complete entry tear resection, aortic wall reinforcement and restoration of aortic valve competence were consistently applied. All procedures were performed in accordance with current guidelines for the surgical management of acute type A aortic dissection. Data endpoint The primary endpoint of this study was in-hospital mortality, defined as death from any cause occurring during the same hospitalization. All laboratory parameters were collected within 24–48 h prior to surgery. The HALP index was calculated using the following formula [19]: Acute kidney injury was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 persisting for ≥3 months, or serum creatinine ≥133 μmol/L in males or ≥115 μmol/L in females [20]. Acute hepatic insufficiency was defined as serum albumin <35 g/L or total bilirubin >34 μmol/L, accompanied by coagulopathy (INR ≥1.5) and clinical manifestations such as jaundice or hepatic encephalopathy [21]. Cerebral infarction was defined as focal ischemic necrosis of brain tissue confirmed by imaging (CT/MRI), with neurological deficits lasting ≥24 h [22]. Respiratory failure was defined as the need for mechanical ventilation >48 h postoperatively, or reintubation/mechanical ventilation after extubation [23]. Additionally, other endpoints were collected, including length of hospital stay and ICU stay duration. Data collection All data were obtained from the hospital’s electronic medical record and laboratory information systems. Data extraction and verification were performed independently by two researchers, with discrepancies resolved by a third investigator. The collected variables included: (1) demographic characteristics: age, sex, body mass index (BMI); (2) preoperative comorbidities: diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), AF; (3) preoperative laboratory tests: haemoglobin, albumin, lymphocyte count, platelet count and serum creatinine; (4) echocardiographic parameters: left ventricular ejection fraction (LVEF); (5) surgical factors: type A aortic dissection repair, CPB time, aortic cross-clamp time and EuroSCORE II; (6) postoperative outcomes: in-hospital mortality, acute kidney injury, acute liver dysfunction, respiratory failure, ICU length of stay, and mechanical ventilation duration. Data analysis All statistical analyses were performed using Python 3.10 and SPSS version 26.0 (SPSS Inc., Chicago, IL). The Shapiro–Wilk test was applied to assess the normality of continuous variables. Normally distributed data were expressed as mean ± standard deviation (M ± SD) and compared between groups using independent-samples t-tests. Non-normally distributed data were presented as median and interquartile range, with group comparisons conducted using the Mann–Whitney U-test. Categorical variables were expressed as counts (percentages) and compared using the χ2 test or Fisher’s exact test. Receiver operating characteristic (ROC) curve analysis was performed to evaluate predictive ability, with the area under the curve (AUC) calculated; the DeLong test was used to compare AUCs between models. Multicollinearity was assessed using variance inflation factors (VIFs), with a threshold of VIF > 5; variables exhibiting significant collinearity were not simultaneously included in the model. Candidate variables were first screened through univariate logistic regression, and those with p < 0.1 were considered for inclusion in the multivariate model. After multicollinearity assessment (VIF > 5), multivariate logistic regression was performed using a forced-entry method to identify independent risk factors for in-hospital mortality. Model calibration was assessed using the Hosmer–Lemeshow goodness-of-fit test and visualized with calibration curves, with bootstrap resampling (n = 2000) applied to evaluate stability. A two-tailed p < 0.05 was considered statistically significant. Ethical consideration This study was conducted as a retrospective cohort analysis. The study protocol was approved by the Ethics Committee of Putian University Affiliated Hospital (Approval No. 2026569) and strictly adhered to the principles of the Declaration of Helsinki. As the study involved only the collection and analysis of existing clinical data without patient intervention, and all data were anonymized, the requirement for informed consent was waived by the ethics committee. Results Baseline characteristics This study included a total of 764 consecutive patients scheduled for type A aortic dissection surgery with CPB. Fourteen patients were excluded: eight did not undergo surgery and six had incomplete admission or intraoperative data. Ultimately, 750 patients met the inclusion criteria and were enrolled in the study (see Figure 1). Among them, 654 patients survived hospitalization, while 96 patients died, yielding an in-hospital mortality rate of 12.8%. Flowchart of patient selection. The mortality group was significantly older than the survival group (68.2 ± 9.4 vs. 61.9 ± 10.3 years, p < 0.001). No significant differences were observed between the two groups in terms of sex, BMI, smoking history, alcohol consumption, hypertension or diabetes mellitus (p = 0.471). However, CKD was significantly more prevalent in the mortality group (19.8% vs. 8.9%, p = 0.002) (Table 1). Table 1.Baseline demographic, clinical characteristics of the study population stratified by in-hospital mortality (n = 750).VariablesSurvival group (n = 654)Death group (n = 96) p Baseline characteristics Age (years, M ± SD)61.9 ± 10.368.2 ± 9.4<0.001 BMI (kg/m², M ± SD)24.7 ± 3.224.2 ± 3.50.189 LVEF (%, M ± SD)55.1 ± 7.551.6 ± 8.3<0.001 EuroSCORE II (%, M ± SD)4.5 ± 2.97.2 ± 4.1<0.001 Male sex, n (%)380 (58.1%)54 (56.3%)0.816 Alcohol history, n (%)237 (36.2%)38 (39.6%)0.602 Smoking history, n (%)215 (32.9%)33 (34.4%)0.861 Hypertension, n (%)371 (56.7%)57 (59.4%)0.705 Diabetes mellitus, n (%)184 (28.1%)31 (32.3%)0.471 Chronic kidney disease, n (%)58 (8.9%)19 (19.8%)0.002Comorbidities COPD38 (5.8%)7 (7.3%)0.733 Malperfusion syndrome, n (%)178 (27.2%)40 (41.7%)0.005 Chronic heart failure, n (%)32 (4.9%)9 (9.4%)0.118 Atrial fibrillation, n (%)96 (14.7%)16 (16.7%)0.721 Prior myocardial infarction (%)119 (18.2%)30 (31.3%)0.004 Cardiac tamponade, n (%)142 (21.7%)24 (25.0%)0.553 Moderate-severe aortic regurgitation, n (%)228 (34.9%)37 (38.5%)0.555 Acute renal insufficiency, n (%)47 (7.2%)14 (14.6%)0.023 Respiratory failure, n (%)22 (3.4%)7 (7.3%)0.082Surgical procedures Ascending aorta replacement alone, n (%)246 (37.6%)28 (29.2%)0.132 Hemiarch replacement, n (%)284 (43.4%)42 (43.8%)0.951 Total arch replacement, n (%)84 (12.8%)14 (14.6%)0.653 Aortic valve replacement, n (%)156 (23.8%)30 (31.3%)0.118 Valve-sparing root replacement, n (%)30 (4.6%)8 (8.3%)0.139 Concomitant CABG, n (%)22 (3.4%)5 (5.2%)0.398BMI: body mass index; COPD: chronic obstructive pulmonary disease.*p < 0.05 was considered statistically significant. Baseline demographic, clinical characteristics of the study population stratified by in-hospital mortality (n = 750). BMI: body mass index; COPD: chronic obstructive pulmonary disease. *p < 0.05 was considered statistically significant. Comparison of preoperative, intraoperative and postoperative parameters As shown in Table 2, preoperative laboratory tests revealed that albumin and lymphocyte count were significantly lower in the mortality group (both p < 0.05), while haemoglobin (p = 0.121) and platelet count (p = 0.244) did not differ significantly between the two groups. Serum creatinine also showed no significant difference (p = 0.081). The HALP index was significantly lower in the mortality group (49.27 ± 15.06 vs. 71.53 ± 25.98, p < 0.001). The prevalence of malperfusion syndrome was significantly higher in the mortality group (41.7% vs. 27.2%, p = 0.005). Intraoperatively, patients in the mortality group had longer CPB times (102.5 ± 32.4 vs. 92.4 ± 25.6 min, p = 0.003). However, blood loss (610 ± 195 vs. 585 ± 170 mL, p = 0.236) and red blood cell transfusion volume (2.3 ± 1.1 vs. 2.1 ± 1.0 units, p = 0.095) did not differ significantly between groups. Postoperatively, both ICU stay (4.5 ± 2.3 vs. 3.2 ± 1.4 days, p < 0.001) and mechanical ventilation duration (24.8 ± 11.5 vs. 18.6 ± 6.9 h, p < 0.001) were significantly prolonged in the mortality group. The incidence of acute kidney injury was significantly higher (41.7% vs. 14.1%, p < 0.001), and severe infections were more frequent (18.8% vs. 11.0%, p = 0.044). Table 2.Comparison of preoperative, intraoperative and postoperative indicators between groups.CategoryVariablesSurvival group (n = 654)Death group (n = 96) p PreoperativeHaemoglobin (g/L)128.6 ± 14.2126.0 ± 15.40.121 Albumin (g/L)39.8 ± 4.638.5 ± 4.80.015 Lymphocyte (×109/L)1.65 ± 0.521.42 ± 0.560.001 Platelet (×109/L)210.4 ± 58.7202.6 ± 61.30.244 HALP index71.53 ± 25.9849.27 ± 15.06<0.001 Serum creatinine (μmol/L)98.2 ± 21.5103.8 ± 30.10.081IntraoperativeCPB time (min)92.4 ± 25.6102.5 ± 32.40.003 Aortic cross-clamp (min)65.7 ± 18.970.2 ± 22.60.067 Lowest temperature (°C)32.8 ± 1.232.6 ± 1.40.186 Urine output (mL)820 ± 210790 ± 2000.196 Blood loss (mL)585 ± 170610 ± 1950.236 RBC transfusion (units)2.1 ± 1.02.3 ± 1.10.095PostoperativeICU stay (days)3.2 ± 1.44.5 ± 2.3<0.001 Mechanical ventilation time (h)18.6 ± 6.924.8 ± 11.5<0.001 Acute kidney injury, n (%)92 (14.1%)40 (41.7%)<0.001 Acute liver dysfunction, n (%)33 (5.0%)8 (8.3%)0.279 Respiratory failure, n (%)111 (17.0%)21 (21.9%)0.301 Stroke, n (%)59 (9.0%)13 (13.5%)0.223 Severe infection, n (%)72 (11.0%)18 (18.8%)0.044HALP: haemoglobin, albumin, lymphocyte and platelet; LVEF: left ventricular ejection fraction; CPB: cardiopulmonary bypass; RBC: red blood cell; ICU: intensive care unit.*p < 0.05 was considered statistically significant. Comparison of preoperative, intraoperative and postoperative indicators between groups. HALP: haemoglobin, albumin, lymphocyte and platelet; LVEF: left ventricular ejection fraction; CPB: cardiopulmonary bypass; RBC: red blood cell; ICU: intensive care unit. *p < 0.05 was considered statistically significant. Univariate and multivariate logistic regression analysis Univariate analysis indicated that age, diabetes, CKD, malperfusion syndrome, LVEF, EuroSCORE II and low HALP levels were associated with in-hospital mortality. Multivariate analysis further confirmed age (OR = 1.06, 95% CI: 1.01–1.12, p = 0.018), CKD (OR = 2.71, 95% CI: 1.13–6.49, p = 0.025), LVEF (OR = 0.92, 95% CI: 0.87–0.97, p = 0.003) and low HALP (OR = 2.87, 95% CI: 1.38–5.97, p = 0.004) as independent risk factors for in-hospital mortality. Malperfusion syndrome, although significantly associated with mortality in univariate analysis, did not remain an independent predictor after adjustment for other confounders (as shown in Table 3 and Figure 2). Table 3.Univariate and multivariate logistic regression analysis for in-hospital mortality.VariablesUnivariate analysisMultivariate analysisOR (95% CI) p OR (95% CI) p Age1.07 (1.02–1.12)0.0031.06 (1.01–1.12)0.018Chronic kidney disease2.94 (1.29–6.71)0.0092.71 (1.13–6.49)0.025Diabetes mellitus2.08 (1.01–4.29)0.046––Malperfusion syndrome1.91 (1.23–2.97)0.005––LVEF0.91 (0.86–0.96)0.0320.92 (0.87–0.97)0.003EuroSCORE II1.14 (1.05–1.26)0.004––Low HALP (<46.32)3.18 (1.62–6.25)0.0012.87 (1.38–5.97)0.004OR: odds ratio; CI: confidence interval; LVEF: left ventricular ejection fraction; HALP: haemoglobin, albumin, lymphocyte and platelet.*p < 0.05 was considered statistically significant. Univariate and multivariate logistic regression analysis for in-hospital mortality. OR: odds ratio; CI: confidence interval; LVEF: left ventricular ejection fraction; HALP: haemoglobin, albumin, lymphocyte and platelet. *p < 0.05 was considered statistically significant. Forest plot of risk factors for in-hospital mortality after CPB cardiac surgery. LVEF: left ventricular ejection fraction. Comparison of predictive performance As shown in Figure 3, ROC curve analysis demonstrated limited predictive performance for single factors: age (AUC = 0.60), CKD (AUC = 0.65) and LVEF (AUC = 0.65). HALP showed superior predictive ability (AUC = 0.74), outperforming each individual indicator. The combined model incorporating age, CKD, LVEF and HALP achieved the highest predictive performance (AUC = 0.79), which was significantly better than that of any single variable (all p < 0.05 by the DeLong test), suggesting that a multifactorial approach provides superior identification of high-risk patients. The calibration curve of the combined model demonstrated good agreement between predicted probabilities and observed outcomes across the full range of risk (Hosmer–Lemeshow χ2 = 5.7, p = 0.682; Figure 4). Bootstrap resampling (n = 2000) confirmed the stability of the calibration. Receiver operating characteristic (ROC) curves for HALP and conventional predictors. AUC values: HALP = 0.74 (cutoff: 46.32), age = 0.60, CKD = 0.65, LVEF = 0.65, combined model = 0.79. CKD: chronic kidney disease; LVEF: left ventricular ejection fraction; HALP: haemoglobin, albumin, lymphocyte and platelet. Calibration curve of the prediction model. The solid line represents the model calibration, the dashed line represents perfect prediction, and the shaded area indicates the 95% confidence interval. Hosmer–Lemeshow (H–L) statistic = 5.7, p = 0.682, with 2000 bootstrap resamples, indicating good model calibration. Discussion This study is the first to systematically evaluate the prognostic value of the preoperative HALP index for in-hospital mortality after type A aortic dissection surgery with CPB. The main findings were as follows: (1) patients in the mortality group had significantly lower HALP scores compared with survivors; (2) patients with low HALP (<46.32) had markedly higher mortality rates than those with high HALP; (3) multivariate analysis confirmed HALP as an independent predictor of in-hospital mortality; and (4) the predictive performance of HALP (AUC = 0.74) was superior to other single indicators. These results suggest that HALP may serve as a valuable supplementary tool for perioperative risk stratification in type A aortic dissection surgery, thereby supporting precision management and improving patient outcomes [24]. Type A aortic dissection surgery with CPB is a high-risk emergency procedure, and its perioperative mortality remains at a high level. This elevated risk is largely attributable to systemic inflammatory responses, ischemia–reperfusion injury and immune dysregulation induced by CPB and aortic dissection itself [25]. Therefore, establishing effective risk stratification tools in this population is of particular importance. The HALP index, as an integrated score combining nutritional, inflammatory and hematologic parameters, derives its predictive value from the synergistic effects of its components. In this study, patients in the mortality group exhibited significantly lower levels of multiple hematologic indicators compared with survivors, suggesting that multidimensional nutritional deficiency, inflammatory activation and immune suppression jointly contribute to adverse outcomes. Reduced haemoglobin not only indicates impaired tissue oxygen delivery but is also closely associated with chronic inflammation and malnutrition [26]. Furthermore, haemodilution and haemolysis during CPB exacerbate anaemia-related organ dysfunction. Hypoalbuminaemia reflects malnutrition and systemic inflammation [27]. Previous studies have demonstrated that hypoalbuminaemia is strongly associated with postoperative complications and increased mortality in aortic dissection surgery [28], consistent with our current findings. Lymphopaenia is a hallmark of immune suppression and malnutrition. Patients with type A aortic dissection often suffer from severe systemic stress, leading to neuroendocrine activation and inflammatory cytokine release, which in turn promote lymphocyte apoptosis [29]. In this study, lymphocyte counts were significantly lower in the mortality group, highlighting the link between immune suppression and poor prognosis. Moreover, postoperative infectious complications were closely associated with preoperative lymphopaenia, as immune suppression predisposes patients to severe infections [30]. Additionally, thrombocytopenia not only impairs coagulation but also reflects inflammation and bone marrow suppression, ultimately contributing to adverse postoperative outcomes. Taken together, the HALP index integrates haemoglobin, albumin, lymphocyte count and platelet count to comprehensively reflect nutritional, inflammatory and immune status [31]. Its significant reduction is strongly associated with in-hospital mortality, underscoring its independent predictive value in risk stratification for patients undergoing type A aortic dissection surgery with CPB. Our findings are consistent with previous studies demonstrating the prognostic value of the HALP index in cardiovascular surgery. Koyuncu and Koyun [32] reported that a low HALP score was independently associated with 30-day mortality after coronary artery bypass grafting, and Keten et al. [33] confirmed its predictive value for long-term mortality following transcatheter aortic valve replacement. However, unlike these studies, our cohort exclusively comprised type A aortic dissection patients undergoing surgical repair with CPB, a population characterized by more severe systemic inflammation, greater hemodynamic instability and more extensive surgical trauma [34]. The distinct pathophysiology of TAAD and the added burden of CPB may amplify the prognostic signal captured by HALP, which could partly explain why HALP showed comparable or even favourable performance in our cohort (AUC = 0.74) relative to its performance in other cardiac surgical populations. Furthermore, compared with other commonly used indices such as PNI (which relies solely on albumin and lymphocyte count) [35] or PLR (which reflects only the PLR) [36], HALP integrates four complementary dimensions – oxygen-carrying capacity, nutritional status, immune function and inflammatory activity – into a single metric. In a direct comparison of 239 CABG patients, Koyuncu and Koyun reported that HALP achieved slightly higher sensitivity (81% vs. 79%) and specificity (82% vs. 80%) than PNI for predicting 30-day mortality, with both identified as independent predictors [32]. This allows HALP to more comprehensively capture the complex interplay of hemodynamic compromise, systemic inflammation and immune suppression in TAAD surgery. These findings validate HALP’s role in cardiovascular surgical risk stratification and extend its applicability to this high-risk population. The clinical implication of this study is that the HALP index, derived from routine laboratory parameters, is simple to calculate and cost-effective, providing a valuable supplement to existing risk scoring systems for type A aortic dissection surgery without imposing additional burden. More importantly, the HALP index can help identify patients at higher perioperative risk of mortality at the time of admission. Although acute TAAD requires emergency surgery and a low HALP does not alter the surgical indication, it can meaningfully inform perioperative preparation and management. Specifically, patients with low HALP values may benefit from proactive blood product preparation, early optimization of hemodynamic support, and timely reservation of intensive care unit beds. Given that the HALP integrates haemoglobin, albumin, lymphocyte and platelet counts, targeted interventions, such as preoperative albumin supplementation, individualized transfusion strategies and early nutritional support, may help mitigate the elevated risk. Postoperatively, these patients may warrant intensified monitoring of renal function, inflammatory markers and infectious complications, as well as earlier initiation of rehabilitative measures. These strategies may help improve resource allocation and clinical outcomes without delaying life-saving surgery. Limitations This study has several limitations. First, its single-centre retrospective design may introduce selection bias. Second, dynamic changes in HALP were not assessed, limiting insights into its temporal predictive value. Third, although this study included a reasonably sized cohort, a larger sample from extended enrolment or multi-centre collaboration would further strengthen the statistical power and generalizability of the findings. Fourth, some potentially important factors, such as intraoperative variables and postoperative complications specific to aortic dissection, were not included in the analysis. Future multicentre prospective studies with dynamic HALP monitoring and long-term follow-up are warranted to validate the generalizability of our findings and explore targeted perioperative optimization strategies guided by HALP values. Conclusions In summary, the preoperative HALP index is an independent predictor of in-hospital mortality after type A aortic dissection surgery with CPB, demonstrating good discriminatory performance. Derived from routine laboratory parameters, the HALP index is simple, cost-effective and readily applicable in daily practice. Although emergency surgery cannot be deferred, a low HALP at admission can alert the clinical team to optimize perioperative management, including proactive blood product preparation, early nutritional support and intensified postoperative monitoring. Therefore, the HALP index may serve as a useful supplement to conventional risk assessment tools, providing valuable guidance for perioperative risk stratification and resource allocation in type A aortic dissection surgery. Acknowledgements The authors would like to thank the clinical staff of the Affiliated Hospital of Putian University for their support in patient management and data collection. All authors contributed to the conception and design of the study. Zhen Chen and Zongxiang Lin was responsible for data collection, statistical analysis and drafting of the manuscript. Qiuxia Liu and Pengfei Chen contributed to data interpretation and critical revision of the manuscript. Hao Chen supervised the study, provided methodological guidance and finalized the manuscript. All authors read and approved the final version of the manuscript. Funding Statement No funding. Ethical approval This study was conducted as a retrospective cohort analysis. The study protocol was approved by the Ethics Committee of Putian University Affiliated Hospital (Approval No. 2026569) and strictly adhered to the principles of the Declaration of Helsinki. As the study involved only the collection and analysis of existing clinical data without patient intervention, and all data were anonymized, the requirement for informed consent was waived by the ethics committee. Disclosure statement No potential conflict of interest was reported by the author(s). Data availability statement The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request. References Associated Data Data Availability Statement The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.